Cite
Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19
MLA
Markus Blaess, et al. “Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19.” International Journal of Molecular Sciences, vol. 22, no. 4, Feb. 2021, p. 1797. EBSCOhost, https://doi.org/10.3390/ijms22041797.
APA
Markus Blaess, Lars Kaiser, Oliver Sommerfeld, René Csuk, & Hans-Peter Deigner. (2021). Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19. International Journal of Molecular Sciences, 22(4), 1797. https://doi.org/10.3390/ijms22041797
Chicago
Markus Blaess, Lars Kaiser, Oliver Sommerfeld, René Csuk, and Hans-Peter Deigner. 2021. “Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19.” International Journal of Molecular Sciences 22 (4): 1797. doi:10.3390/ijms22041797.